The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan
Al-Sofiani ME, Petrovski G , Al Shaikh A, et al.
Diabetes Obes Metab. Pub. online 27 Dec 2023.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study
Krishnan A, Schneider CV, Hadi Y, et al.
Diabetologia. Pub. online 20 Dec 2023.
Leggi
Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial
Zoungas S, Zhou Z, Owen AJ, et al.
Lancet Diabetes Endocrinol. 2023:S2213-8587(23)00327-3.
Leggi
Do glycaemic treatment targets affect the perinatal mental health status of women with gestational diabetes? – Data from the TARGET Trial
Ohene-Agyei P, Tran T, Harding JE, Crowther CA
BMC Pregnancy Childbirth. 2023;23(1):869.
Leggi
Diagnostic yield of a proactive strategy for early detection of cardiovascular disease versus usual care in adults with type 2 diabetes or chronic obstructive pulmonary disease in primary care in the Netherlands (RED-CVD): a multicentre, pragmatic, cluster-randomised, controlled trial
Groenewegen A, Zwartkruis VW, Rienstra M, et al.
Lancet Public Health. 2023:S2468-2667(23)00269-4.
Leggi
Translating trial results into interpretable risk estimates: systematic analysis of cardiorenal outcome trials of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors
Rizzi A, Kloecker DE, Pitocco D, et al.
NMCD. Pub. online 19 Dec 2023.
Leggi
Once‐weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis
Kobo O, Cavender MA, Jensen TJ, et al.
Diabetes Obes Metab. Pub. online 11 Dec 2023.
Leggi
Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials
Munshi M, Ritzel R, Jude EB, et al.
Diabetes Obes Metab. Pub. online 11 Dec 2023.
Leggi
Safety, pharmacokinetics and pharmacodynamics of HRS‐7535, a novel oral small molecule glucagon‐like peptide‐1 receptor agonist, in healthy participants: A phase 1, randomized, double‐blind, placebo‐controlled, single‐ and multiple‐ascending dose, and food effect trial
Wu J, Zhou R, Zhang Q, et al.
Diabetes Obes Metab. Pub. online 15 Dec 2023.
Leggi
A novel model for predicting diabetes remission after bariatric surgery based on the measurement of C-peptide and creatinine in serum: a pilot study
Colosimo S, Martínez-Sánchez MA, Balaguer-Román A, et al.
NMCD. Pub. online, 16 Dec 2023.
Leggi